CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,312,833 | -20.0% | 544,196 | 0.0% | 7.30% | -17.6% |
| Q1 2023 | $2,889,681 | -15.4% | 544,196 | 0.0% | 8.86% | -21.4% |
| Q4 2022 | $3,417,551 | -40.5% | 544,196 | 0.0% | 11.27% | -42.2% |
| Q3 2022 | $5,741,000 | +73.5% | 544,196 | -10.7% | 19.52% | +78.5% |
| Q2 2022 | $3,308,000 | -46.6% | 609,196 | -9.6% | 10.93% | +52.5% |
| Q1 2022 | $6,189,000 | -39.2% | 674,196 | 0.0% | 7.17% | +12.1% |
| Q4 2021 | $10,174,000 | -36.8% | 674,196 | 0.0% | 6.39% | -36.2% |
| Q3 2021 | $16,093,000 | – | 674,196 | – | 10.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $11,316,000 | 14.13% |
| Memorial Sloan Kettering Cancer Center | 674,196 | $16,093,000 | 10.03% |
| PFM Health Sciences, LP | 4,092,309 | $88,176,000 | 2.59% |
| CloudAlpha Capital Management Limited/Hong Kong | 305,000 | $7,280,000 | 2.15% |
| Monashee Investment Management LLC | 449,377 | $10,727,000 | 1.98% |
| Avidity Partners Management LP | 2,474,067 | $59,056,000 | 1.31% |
| Green Alpha Advisors, LLC | 32,836 | $784,000 | 0.54% |
| Tekla Capital Management LLC | 699,377 | $15,621,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $4,774,000 | 0.40% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 | $70,738,000 | 0.33% |